Elizabeth Parrish, CEO of Bioviva USA Inc, has undergone a gene therapy, created by her own company that has reversed 20 years of telomere shortening. This makes Parrish the first human to be successfully rejuvenated by gene therapy. Telomere score is calculated according to telomere length of white blood cells (T-lymphocytes). This result is based on the average T-lymphocyte telomere length compared to the American population at the same age range. The higher the telomere score, the “younger” the cells.
Continue reading… “Gene therapy against human aging successful”













